PCM
JBIO

Prelude Capital Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History

Prelude Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,127
Closed -$290K – 1097
2024
Q4 		$290K Buy
+3,127
New +$290K 0.02% 703
2024
Q2 		– Sell
-591
Closed -$612K – 1125
2024
Q1 		$612K Buy
+591
New +$612K 0.03% 485